2024 Q4 Form 10-Q Financial Statement
#000089710124000572 Filed on November 13, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
Revenue | $2.512M | |
YoY Change | 22.12% | |
Cost Of Revenue | $1.247M | |
YoY Change | 17.2% | |
Gross Profit | $1.265M | |
YoY Change | 27.39% | |
Gross Profit Margin | 50.36% | |
Selling, General & Admin | $857.0K | |
YoY Change | 6.99% | |
% of Gross Profit | 67.75% | |
Research & Development | $235.0K | |
YoY Change | 7.8% | |
% of Gross Profit | 18.58% | |
Depreciation & Amortization | $23.00K | |
YoY Change | 15.0% | |
% of Gross Profit | 1.82% | |
Operating Expenses | $1.092M | |
YoY Change | 7.16% | |
Operating Profit | $173.0K | |
YoY Change | -765.38% | |
Interest Expense | $117.0K | |
YoY Change | 6.36% | |
% of Operating Profit | 67.63% | |
Other Income/Expense, Net | $117.0K | |
YoY Change | 7.34% | |
Pretax Income | $290.0K | |
YoY Change | 249.4% | |
Income Tax | $52.00K | |
% Of Pretax Income | 17.93% | |
Net Earnings | $238.0K | |
YoY Change | 2875.0% | |
Net Earnings / Revenue | 9.47% | |
Basic Earnings Per Share | $0.07 | |
Diluted Earnings Per Share | $0.07 | |
COMMON SHARES | ||
Basic Shares Outstanding | 3.428M shares | 3.428M shares |
Diluted Shares Outstanding | 3.434M shares |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $10.30M | |
YoY Change | 3.77% | |
Cash & Equivalents | $10.25M | |
Short-Term Investments | $56.00K | |
Other Short-Term Assets | $240.0K | |
YoY Change | -13.98% | |
Inventory | $2.003M | |
Prepaid Expenses | ||
Receivables | $1.182M | |
Other Receivables | $32.00K | |
Total Short-Term Assets | $13.76M | |
YoY Change | 3.88% | |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $911.0K | |
YoY Change | 0.44% | |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $287.0K | |
YoY Change | 43.5% | |
Total Long-Term Assets | $1.198M | |
YoY Change | 8.42% | |
TOTAL ASSETS | ||
Total Short-Term Assets | $13.76M | |
Total Long-Term Assets | $1.198M | |
Total Assets | $14.96M | |
YoY Change | 4.23% | |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $220.0K | |
YoY Change | -15.71% | |
Accrued Expenses | $639.0K | |
YoY Change | 14.31% | |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $859.0K | |
YoY Change | 4.63% | |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | |
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $0.00 | |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $859.0K | |
Total Long-Term Liabilities | $0.00 | |
Total Liabilities | $859.0K | |
YoY Change | 4.76% | |
SHAREHOLDERS EQUITY | ||
Retained Earnings | $11.43M | |
YoY Change | 4.0% | |
Common Stock | $2.670M | |
YoY Change | 4.99% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $14.10M | |
YoY Change | ||
Total Liabilities & Shareholders Equity | $14.96M | |
YoY Change | 4.23% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $238.0K | |
YoY Change | 2875.0% | |
Depreciation, Depletion And Amortization | $23.00K | |
YoY Change | 15.0% | |
Cash From Operating Activities | $362.0K | |
YoY Change | 57.39% | |
INVESTING ACTIVITIES | ||
Capital Expenditures | $4.000K | |
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | -$4.000K | |
YoY Change | -99.79% | |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 0.000 | |
YoY Change | -100.0% | |
NET CHANGE | ||
Cash From Operating Activities | 362.0K | |
Cash From Investing Activities | -4.000K | |
Cash From Financing Activities | 0.000 | |
Net Change In Cash | 358.0K | |
YoY Change | -121.06% | |
FREE CASH FLOW | ||
Cash From Operating Activities | $362.0K | |
Capital Expenditures | $4.000K | |
Free Cash Flow | $358.0K | |
YoY Change | 55.65% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
0 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
911000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
80000 | usd | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.07 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
63000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1621000 | usd | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3428021 | shares |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
96000 | usd | |
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
61000 | usd | |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
238000 | usd |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-71000 | usd | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.02 | ||
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
14098000 | usd |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
|
0 | usd | |
dei |
Local Phone Number
LocalPhoneNumber
|
930-0100 | ||
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
8000 | usd |
CY2024Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3434417 | shares |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13529000 | usd |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
69000 | usd | |
CY2023Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
0 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
80000 | usd | |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13484000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13755000 | usd |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
175000 | shares |
ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | ||
ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | ||
ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | ||
ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | ||
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
CY2024Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000351789 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
ELECTRO SENSORS INC | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
000-09587 | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
MN | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
41-0943459 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
6111 Blue Circle Drive | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Minnetonka | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MN | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
55343-9108 | ||
dei |
City Area Code
CityAreaCode
|
952 | ||
dei |
Security12b Title
Security12bTitle
|
Common stock, $0.10 par value | ||
dei |
Trading Symbol
TradingSymbol
|
ELSE | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
3428021 | shares |
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
10246000 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9870000 | usd |
CY2024Q3 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
56000 | usd |
CY2023Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
56000 | usd |
CY2024Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
11000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
11000 | usd |
CY2024Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1182000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1283000 | usd |
CY2024Q3 | us-gaap |
Inventory Net
InventoryNet
|
2003000 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
1751000 | usd |
CY2024Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
240000 | usd |
CY2023Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
179000 | usd |
CY2024Q3 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
32000 | usd |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
13759000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
13139000 | usd |
CY2024Q3 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
287000 | usd |
CY2023Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
355000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
951000 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
14957000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
14445000 | usd |
CY2024Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
220000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
291000 | usd |
CY2024Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
639000 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
323000 | usd |
CY2024Q3 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
0 | usd |
CY2023Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
76000 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
859000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
690000 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.1 | |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.1 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3428021 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3428021 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3428021 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3428021 | shares |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
342000 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
342000 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
2328000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
2230000 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
11428000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
11183000 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
14098000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13755000 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
14957000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
14445000 | usd |
CY2024Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
2512000 | usd |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
2057000 | usd |
us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
6973000 | usd | |
us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
6239000 | usd | |
CY2024Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1247000 | usd |
CY2023Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1064000 | usd |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
3581000 | usd | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
3156000 | usd | |
CY2024Q3 | us-gaap |
Gross Profit
GrossProfit
|
1265000 | usd |
CY2023Q3 | us-gaap |
Gross Profit
GrossProfit
|
993000 | usd |
us-gaap |
Gross Profit
GrossProfit
|
3392000 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
3083000 | usd | |
CY2024Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
340000 | usd |
CY2023Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
307000 | usd |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1044000 | usd | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1021000 | usd | |
CY2024Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
517000 | usd |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
494000 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1458000 | usd | |
CY2024Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
235000 | usd |
CY2023Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
218000 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
761000 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
724000 | usd | |
CY2024Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
1092000 | usd |
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
1019000 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
3426000 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
3203000 | usd | |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
173000 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-26000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-34000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-120000 | usd | |
CY2024Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
0 | usd |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
0 | usd | |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
1000 | usd | |
CY2024Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
117000 | usd |
CY2023Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
109000 | usd |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
342000 | usd | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
297000 | usd | |
CY2024Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
117000 | usd |
CY2023Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
109000 | usd |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
342000 | usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
296000 | usd | |
CY2024Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
290000 | usd |
CY2023Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
83000 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
308000 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
176000 | usd | |
CY2024Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
52000 | usd |
CY2023Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
75000 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
238000 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
8000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
245000 | usd | |
CY2024Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
0 | usd |
CY2023Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-1000 | usd |
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
0 | usd | |
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-3000 | usd | |
CY2024Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
0 | usd |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-1000 | usd |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
0 | usd | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-3000 | usd | |
CY2024Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
238000 | usd |
CY2023Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
7000 | usd |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
245000 | usd | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
77000 | usd | |
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.07 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0 | |
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3428021 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3428021 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3428021 | shares | |
CY2024Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.07 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.07 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.02 | ||
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3428021 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3440382 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3428021 | shares | |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13829000 | usd |
CY2024Q3 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
31000 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
14098000 | usd |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-1000 | usd |
CY2023Q3 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
38000 | usd |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
98000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
245000 | usd | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13414000 | usd |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-3000 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
38000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
80000 | usd | |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13529000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
245000 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
70000 | usd | |
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
68000 | usd | |
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
58000 | usd | |
us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
98000 | usd | |
us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
38000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-101000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-95000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
252000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
91000 | usd | |
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
65000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-13000 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
316000 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
209000 | usd | |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-108000 | usd | |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-125000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
406000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
255000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
30000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-30000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1000 | usd | |
us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
0 | usd | |
us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
5000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-5000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
376000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
249000 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9870000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9625000 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
10246000 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9874000 | usd |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
101000 | usd | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
164000 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
1000 | usd | |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
11000 | usd |
CY2024Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
11000 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin: 0pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; line-height: inherit;">Use of Estimates</span></p> <p style="margin: 0pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 8pt; line-height: inherit;"> </span></p> <p style="margin: 0pt; line-height: 1.2;"><span style="font-family: 'Times New Roman'; font-size: 10pt; margin: 0pt; line-height: inherit;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Current significant estimates, including the underlying assumptions, consist of economic lives of long-lived assets, realizability of trade receivables, and valuation of deferred tax assets/liabilities, inventory, investments, and stock compensation expense. It is at least reasonably possible that these estimates may change in the near term</span>. </span></p> | ||
us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="margin: 0in 0in 0.0001pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-align: left; line-height: 1.2;"><span style="font-weight: bold; line-height: inherit;">Reclassification of Prior Year Presentation</span></p> <p style="margin: 0in 0in 0.0001pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-align: left; line-height: 1.2;"><br/></p> <p style="margin: 0in 0in 0.0001pt; font-size: 10pt; font-family: 'Times New Roman', serif; text-align: left; line-height: 1.2;">All Treasury Bills from prior periods have been reclassified to cash equivalents for consistency with the current year presentation. The reclassification had no effect on the reported results of operations. The Balance Sheet and Statement of Cash Flows have been adjusted to reflect this reclassification.</p> | ||
else |
Number Of Private Companies Which Entity Has Investments In Common Equity Securities
NumberOfPrivateCompaniesWhichEntityHasInvestmentsInCommonEquitySecurities
|
2 | ||
CY2024Q3 | else |
Available For Sale Marketable Securities Amortized Cost
AvailableForSaleMarketableSecuritiesAmortizedCost
|
54000 | usd |
CY2024Q3 | else |
Available For Sale Marketable Securities Accumulated Gross Unrealized Gain
AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedGain
|
2000 | usd |
CY2024Q3 | else |
Available For Sale Marketable Securities Accumulated Gross Unrealized Loss
AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedLoss
|
0 | usd |
CY2024Q3 | us-gaap |
Marketable Securities
MarketableSecurities
|
56000 | usd |
CY2023Q4 | else |
Available For Sale Marketable Securities Amortized Cost
AvailableForSaleMarketableSecuritiesAmortizedCost
|
54000 | usd |
CY2023Q4 | else |
Available For Sale Marketable Securities Accumulated Gross Unrealized Gain
AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedGain
|
2000 | usd |
CY2023Q4 | else |
Available For Sale Marketable Securities Accumulated Gross Unrealized Loss
AvailableForSaleMarketableSecuritiesAccumulatedGrossUnrealizedLoss
|
0 | usd |
CY2023Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
56000 | usd |
else |
Number Of Private Companies Which Entity Has Investments In Common Equity Securities
NumberOfPrivateCompaniesWhichEntityHasInvestmentsInCommonEquitySecurities
|
2 | ||
else |
Number Of Private Companies Which Entity Has Investments In Common Equity Securities
NumberOfPrivateCompaniesWhichEntityHasInvestmentsInCommonEquitySecurities
|
2 | ||
CY2023Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
56000 | usd |
CY2022Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
56000 | usd |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
|
0 | usd | |
CY2024Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
56000 | usd |
CY2023Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
56000 | usd |
CY2024Q3 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
1329000 | usd |
CY2023Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
1172000 | usd |
CY2024Q3 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
299000 | usd |
CY2023Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
301000 | usd |
CY2024Q3 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
385000 | usd |
CY2023Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
288000 | usd |
CY2024Q3 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
10000 | usd |
CY2023Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
10000 | usd |
CY2024Q3 | us-gaap |
Inventory Net
InventoryNet
|
2003000 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
1751000 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.2507 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0465 | pure | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | ||
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
175000 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.06 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
300000 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.36 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
25000 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
4.13 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
100000 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
4.11 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares | |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
25000 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
4.39 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
225000 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
4.57 | ||
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.04 | |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
175000 | shares |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.03 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
95000 | shares |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.8 | |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
50000 | shares |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
4.21 | |
us-gaap |
Loss Contingency Disclosures
LossContingencyDisclosures
|
<p style="margin: 0in; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1;"><b><span style="font-size: 10pt; line-height: inherit;">Note 6. Contingencies</span></b><span style="font-size: 10pt; line-height: inherit;"></span></p> <p style="margin: 0in; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1;"><span style="font-size: 10pt; line-height: inherit;"> </span></p> <p style="margin: 0in; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit;">The Company at times becomes subject to claims against it in the ordinary course of business. There are currently no pending or threatened claims against the Company that it believes will have a material adverse effect on its results of operations or liquidity.</span></p> |